Third Wave Technologies, Inc.

Analysis of genetic variations, SNP, assay systems for use on microarray platforms

Third Wave currently employs approximately 175 people. Among its top competitors are Nanogen, Orchid BioSciences and Sequenom.

Kevin Conroy (CEO)
Jim Herrmann (VP, Finance)

David A. Thompson (Chairman)
James Connelly
Kevin Conroy
Lawrence J. Murphy
Gordon F. Brunner
John Neis
Lionel N. Sterling

502 S. Rosa Road
Madison, WI 53719
USA
Phone: +1-608-273-8933
Fax: +1-608-273-8618

The Invader® RNA Assay products are designed for the direct quantification of RNA (e.g. cytochrome P450, cytokines, chemokines, housekeeping genes, growth factors).